Balance Sheet Breakdown: Humana Inc. (HUM)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $316.74 in the prior trading day, Humana Inc. (NYSE: HUM) closed at $279.45, down -11.77%. In other words, the price has decreased by -$11.77 from its previous closing price. On the day, 7.02 million shares were traded. HUM stock price reached its highest trading level at $315.055 during the session, while it also had its lowest trading level at $276.795.

Ratios:

Our goal is to gain a better understanding of HUM by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.70.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on June 26, 2024, initiated with a Overweight rating and assigned the stock a target price of $392.

On June 24, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $374.

BofA Securities Downgraded its Buy to Neutral on April 02, 2024, whereas the target price for the stock was revised from $470 to $342.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 20 ’24 when Mesquita Jorge S. bought 545 shares for $367.09 per share. The transaction valued at 200,066 led to the insider holds 2,578 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 33646340096 and an Enterprise Value of 24048244736. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.92, and their Forward P/E ratio for the next fiscal year is 14.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 2.02. Its current Enterprise Value per Revenue stands at 0.215 whereas that against EBITDA is 5.642.

Stock Price History:

Over the past 52 weeks, HUM has reached a high of $530.54, while it has fallen to a 52-week low of $298.61. The 50-Day Moving Average of the stock is -19.97%, while the 200-Day Moving Average is calculated to be -23.11%.

Shares Statistics:

The stock has traded on average 1.24M shares per day over the past 3-months and 1961880 shares per day over the last 10 days, according to various share statistics. A total of 122.22M shares are outstanding, with a floating share count of 120.10M. Insiders hold about 0.25% of the company’s shares, while institutions hold 95.60% stake in the company. Shares short for HUM as of 1726185600 were 2236285 with a Short Ratio of 1.80, compared to 1723680000 on 2248643. Therefore, it implies a Short% of Shares Outstanding of 2236285 and a Short% of Float of 1.8599999999999999.

Dividends & Splits

In the trailing 12 months, HUM’s forward annual dividend rate was 3.54, compared to 3.54 this year. Against a Trailing Annual Dividend Yield of 0.01117636The stock’s 5-year Average Dividend Yield is 0.7.

Most Popular